Empagliflozin is an SGLT2 inhibitor used to treat type 2 diabetes, heart failure, and chronic kidney disease. It works by helping the kidneys remove excess glucose through the urine while also promoting sodium and fluid excretion.

Benefits:

• Helps lower blood glucose levels
• Can support weight loss through urinary glucose loss
• Reduces the risk of hospitalisation for heart failure
• Provides kidney-protective benefits in appropriate patients
• May help reduce cardiovascular risk

Potential Side Effects:

• Increased urination and thirst
• Genital yeast infections or urinary tract infections
• Dehydration or dizziness
• Rarely, diabetic ketoacidosis